Skip to search.
 TSX Up 0.36% TSX Ventures Up 0.09%

More On CXM

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

(CXM)

-NYSE MKT
0.76 Down 0.04(4.99%) Jan 23, 3:50PM EST - Nasdaq Real Time Price
Prev Close:N/A
Open:0.76
Bid:N/A
Ask:N/A
1y Target Est:2.00
Beta:4.52
Next Earnings Date:N/A
Day's Range:0.76 - 0.81
52wk Range:0.30 - 0.81
Volume:98,305
Avg Vol (3m):N/A
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-1.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in .

Headlines

  • No Headlines available for CXM at this time.

Comparison

Symbol% ChgMkt Cap
CXMDown 4.99%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cardium Therapeutics, Inc., a medical technology company, engages in the development and commercialization of products and devices for cardiovascular and ischemic diseases, wound healing, and tissue repair. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback